Ouyang, Bichun

An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson’s disease participants

Hall, D. A., Voigt, R. M., Cantu-Jungles, T. M., Hamaker, B., Engen, P. A., Shaikh, M., Raeisi, S., Green, S. J., Naqib, A., Forsyth, C. B., et al. (2023) · Nature Communications

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 124

Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years

Goetz, C. G., Stebbins, G. T., & Ouyang, B. (2011) · Movement Disorders

Hallucinations in medical conditionsParkinson's Disease Mechanisms and Treatments

Cited by 91

Cholesterol levels in Fragile X syndrome

Berry‐Kravis, E., Levin, R., Shah, H., Mathur, S., Darnell, J. C., & Ouyang, B. (2015) · American Journal of Medical Genetics Part A

Genetics and Neurodevelopmental DisordersDown syndrome and intellectual disability research

Cited by 59

Abnormal Lipopolysaccharide Binding Protein as Marker of Gastrointestinal Inflammation in Parkinson Disease

Pal, G. D., Shaikh, M., Forsyth, C. B., Ouyang, B., Keshavarzian, A., & Shannon, K. M. (2015) · Frontiers in Neuroscience

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 57